Eugene Durenard Biography and Net Worth

Director of Co-Diagnostics


Dr. Eugene Durenard serves as Independent Director of the Company. Dr. Durenard is the Founder and CEO of Hyperbolic Holdings, a Swiss-based holding, management consulting and investment advisory company specialized in healthcare since February 2018. He is co-Founder and CIO of Healthcare Impact Holdings, an investment fund specialized in later-stage healthcare private ventures since May 2018. He is co-Founder and Trustee of Healthcare Impact Foundation, a charitable organization designed to sustainably fund the translation of innovation in life sciences since September 2017. He is co-Founder of Global Better Health, a platform designed to provide scientifically-based corporate wellness and preventive programs since December 2018. He is an advisor to and Managing Director of the Stetson Family Office since September 2016. Dr. Durenard brings a thorough multi-asset class investment and entrepreneurial experience spanning 20 years to the Board of Directors. He received his Ph.D. in Mathematics at Harvard in 1995 before beginning his career with Salomon Brothers in London.

What is Eugene Durenard's net worth?

The estimated net worth of Eugene Durenard is at least $2,240.00 as of January 13th, 2021. Dr. Durenard owns 2,000 shares of Co-Diagnostics stock worth more than $2,240 as of March 28th. This net worth approximation does not reflect any other investments that Dr. Durenard may own. Learn More about Eugene Durenard's net worth.

How do I contact Eugene Durenard?

The corporate mailing address for Dr. Durenard and other Co-Diagnostics executives is 2401 SOUTH FOOTHILL DRIVE SUITE D, SALT LAKE CITY UT, 84124. Co-Diagnostics can also be reached via phone at (801) 438-1036 and via email at [email protected]. Learn More on Eugene Durenard's contact information.

Has Eugene Durenard been buying or selling shares of Co-Diagnostics?

Eugene Durenard has not been actively trading shares of Co-Diagnostics during the last ninety days. Most recently, Eugene Durenard sold 2,000 shares of the business's stock in a transaction on Wednesday, September 8th. The shares were sold at an average price of $10.46, for a transaction totalling $20,920.00. Learn More on Eugene Durenard's trading history.

Who are Co-Diagnostics' active insiders?

Co-Diagnostics' insider roster includes Reed Benson (General Counsel), and Eugene Durenard (Director). Learn More on Co-Diagnostics' active insiders.

Eugene Durenard Insider Trading History at Co-Diagnostics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/8/2021Sell2,000$10.46$20,920.00View SEC Filing Icon  
1/13/2021Sell10,500$10.09$105,945.002,000View SEC Filing Icon  
12/10/2020Sell10,000$10.15$101,500.00View SEC Filing Icon  
5/26/2020Sell25,000$18.26$456,500.00View SEC Filing Icon  
5/20/2020Sell25,000$18.40$460,000.00View SEC Filing Icon  
See Full Table

Eugene Durenard Buying and Selling Activity at Co-Diagnostics

This chart shows Eugene Durenard's buying and selling at Co-Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Co-Diagnostics Company Overview

Co-Diagnostics logo
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Read More

Today's Range

Now: $1.12
Low: $1.08
High: $1.14

50 Day Range

MA: $1.17
Low: $1.06
High: $1.30

2 Week Range

Now: $1.12
Low: $0.98
High: $1.89

Volume

63,067 shs

Average Volume

65,684 shs

Market Capitalization

$35.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A